Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensified treatment for tuberculous meningitis to reduce mortality
ISRCTN61649292Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of rifampicin and levofloxacin in meningeal tuberculosis (2 arms), sponsored by University of Oxford. Primary endpoint: Overall survival. Started Apr 2011; status: completed.
02
Drugs
rifampicinlevofloxacin
03
Conditions
meningeal tuberculosis
Beyond the preview
Go deeper on ISRCTN61649292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN61649292.